AR038320A1 - Una dosis de sanorg 34006 para el uso en el tratamiento y profilaxis secundaria de eventos tromboembolicos venosos en pacientes con trombosis venosa profunda - Google Patents
Una dosis de sanorg 34006 para el uso en el tratamiento y profilaxis secundaria de eventos tromboembolicos venosos en pacientes con trombosis venosa profundaInfo
- Publication number
- AR038320A1 AR038320A1 ARP030100237A ARP030100237A AR038320A1 AR 038320 A1 AR038320 A1 AR 038320A1 AR P030100237 A ARP030100237 A AR P030100237A AR P030100237 A ARP030100237 A AR P030100237A AR 038320 A1 AR038320 A1 AR 038320A1
- Authority
- AR
- Argentina
- Prior art keywords
- patients
- dose
- treatment
- sanorg
- profilaxis
- Prior art date
Links
- 206010051055 Deep vein thrombosis Diseases 0.000 title abstract 2
- 206010047249 Venous thrombosis Diseases 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- 208000004043 venous thromboembolism Diseases 0.000 title abstract 2
- -1 2,3,4-tri-O-methyl-6-O-sulfo-alpha-D-glucopyranosyl Chemical group 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Una dosis de 2,5 mg del pentasacárido metil O-(2, 3, 4-tri-O-metil-6-O-sulfo-alfa-D-glucopiranosilo) - (1->4) -O- (ácido 2, 3-di-O-metil-beta-D-glucopiranosil urónico) - (1->4) -O- (2, 3, 6-tri-O-sulfo-alfa-D-glucopiranosilo) - (1->4)-O-( ácido 2, 3-di-O-metil-alfa-L-idopiranosil urónico) - (1->4) -2, 3, 6 -tri-O-sulfo-alfa-D-glucopiranosido o una sal farmacéuticamente aceptable del mismo para el uso en terapia, en particular para el tratamiento y/o profilaxis secundaria de eventos tromboembólicos venosos en pacientes con trombosis venosa profunda.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02075374 | 2002-01-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR038320A1 true AR038320A1 (es) | 2005-01-12 |
Family
ID=27635850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030100237A AR038320A1 (es) | 2002-01-29 | 2003-01-28 | Una dosis de sanorg 34006 para el uso en el tratamiento y profilaxis secundaria de eventos tromboembolicos venosos en pacientes con trombosis venosa profunda |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7709463B2 (es) |
| EP (1) | EP1471924B1 (es) |
| JP (1) | JP4870907B2 (es) |
| CN (1) | CN1622813A (es) |
| AR (1) | AR038320A1 (es) |
| AT (1) | ATE323497T1 (es) |
| AU (1) | AU2003205664B2 (es) |
| BR (1) | BR0307196A (es) |
| CA (1) | CA2472957C (es) |
| CY (1) | CY1107661T1 (es) |
| DE (1) | DE60304678T2 (es) |
| DK (1) | DK1471924T3 (es) |
| EA (1) | EA007204B1 (es) |
| ES (1) | ES2262971T3 (es) |
| MX (1) | MXPA04007310A (es) |
| NO (1) | NO332699B1 (es) |
| PE (1) | PE20030855A1 (es) |
| PL (1) | PL207144B1 (es) |
| PT (1) | PT1471924E (es) |
| SI (1) | SI1471924T1 (es) |
| TW (1) | TWI281861B (es) |
| WO (1) | WO2003063881A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2589770A1 (en) * | 2004-12-01 | 2006-06-08 | Osi Pharmaceuticals, Inc. | N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library |
| WO2012166611A2 (en) | 2011-05-27 | 2012-12-06 | Immune Disease Institute, Inc. | Methods for treating and preventing neutrophil-derived net toxicity and thrombosis |
| EP3997238A1 (en) | 2019-07-09 | 2022-05-18 | Optimvia, LLC | Methods for synthesizing anticoagulant polysaccharides |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5378829A (en) * | 1990-04-23 | 1995-01-03 | Akzo N.V. | Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type |
-
2003
- 2003-01-14 TW TW092100703A patent/TWI281861B/zh not_active IP Right Cessation
- 2003-01-23 AU AU2003205664A patent/AU2003205664B2/en not_active Ceased
- 2003-01-23 MX MXPA04007310A patent/MXPA04007310A/es active IP Right Grant
- 2003-01-23 SI SI200330334T patent/SI1471924T1/sl unknown
- 2003-01-23 WO PCT/EP2003/000696 patent/WO2003063881A1/en not_active Ceased
- 2003-01-23 AT AT03702514T patent/ATE323497T1/de active
- 2003-01-23 CA CA2472957A patent/CA2472957C/en not_active Expired - Fee Related
- 2003-01-23 BR BR0307196-0A patent/BR0307196A/pt not_active Application Discontinuation
- 2003-01-23 US US10/502,706 patent/US7709463B2/en not_active Expired - Fee Related
- 2003-01-23 EP EP03702514A patent/EP1471924B1/en not_active Expired - Lifetime
- 2003-01-23 EA EA200400817A patent/EA007204B1/ru not_active IP Right Cessation
- 2003-01-23 DK DK03702514T patent/DK1471924T3/da active
- 2003-01-23 PL PL370557A patent/PL207144B1/pl unknown
- 2003-01-23 ES ES03702514T patent/ES2262971T3/es not_active Expired - Lifetime
- 2003-01-23 CN CNA038028123A patent/CN1622813A/zh active Pending
- 2003-01-23 JP JP2003563570A patent/JP4870907B2/ja not_active Expired - Fee Related
- 2003-01-23 DE DE60304678T patent/DE60304678T2/de not_active Expired - Lifetime
- 2003-01-23 PT PT03702514T patent/PT1471924E/pt unknown
- 2003-01-23 PE PE2003000071A patent/PE20030855A1/es not_active Application Discontinuation
- 2003-01-28 AR ARP030100237A patent/AR038320A1/es not_active Application Discontinuation
-
2004
- 2004-07-27 NO NO20043195A patent/NO332699B1/no not_active IP Right Cessation
-
2006
- 2006-07-19 CY CY20061101002T patent/CY1107661T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TWI281861B (en) | 2007-06-01 |
| PE20030855A1 (es) | 2003-10-11 |
| DE60304678D1 (de) | 2006-05-24 |
| ES2262971T3 (es) | 2006-12-01 |
| EP1471924B1 (en) | 2006-04-19 |
| WO2003063881A1 (en) | 2003-08-07 |
| ATE323497T1 (de) | 2006-05-15 |
| JP2005519919A (ja) | 2005-07-07 |
| EA200400817A1 (ru) | 2005-02-24 |
| MXPA04007310A (es) | 2004-10-29 |
| CA2472957A1 (en) | 2003-08-07 |
| DE60304678T2 (de) | 2007-04-05 |
| NO20043195L (no) | 2004-10-29 |
| NO332699B1 (no) | 2012-12-10 |
| SI1471924T1 (sl) | 2006-10-31 |
| EP1471924A1 (en) | 2004-11-03 |
| PT1471924E (pt) | 2006-09-29 |
| US20050209175A1 (en) | 2005-09-22 |
| HK1072361A1 (en) | 2005-08-26 |
| CY1107661T1 (el) | 2013-04-18 |
| JP4870907B2 (ja) | 2012-02-08 |
| DK1471924T3 (da) | 2006-08-21 |
| CN1622813A (zh) | 2005-06-01 |
| BR0307196A (pt) | 2004-11-03 |
| PL207144B1 (pl) | 2010-11-30 |
| EA007204B1 (ru) | 2006-08-25 |
| TW200302104A (en) | 2003-08-01 |
| PL370557A1 (en) | 2005-05-30 |
| AU2003205664B2 (en) | 2008-06-05 |
| US7709463B2 (en) | 2010-05-04 |
| CA2472957C (en) | 2011-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY26724A1 (es) | Métodos y composiciones para tratar el virus de la hepatitis c | |
| GEP20063799B (en) | Tropane derivatives useful in therapy | |
| AR049083A1 (es) | Proceso para la preparacion de una forma de dosificacion solida a prueba de abuso | |
| CY1116215T1 (el) | Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης | |
| NO20076613L (no) | Farmasoytiske formuleringer og anvendelse derav | |
| CO5700796A2 (es) | Composiciones que contienen piperacilina y tazobactam utiles para inyecciones | |
| ATE287267T1 (de) | Kombinationstherapien mit gefässschädigender aktivität | |
| AR039164A1 (es) | Sales de venlafaxina de baja solubilidad en agua | |
| ES2570401T3 (es) | Métodos de tratamiento usando dosis únicas de oritavancina | |
| EA200400548A1 (ru) | Лечение тяжёлой пневмонии путём введения ингибитора пути тканевого фактора (tfpi) | |
| UY26678A1 (es) | El uso de composiciones a base de antibióticos de azalidos para tratar o prevenir una infección bacteriana o protozoaria en mamíferos | |
| MXPA02012730A (es) | Uso de acido pamoico o uno de sus derivados o uno de sus analogos para la preparacion de un medicamento para el tratamiento de enfermedades caracterizadas por depositos de agregados de amiloide. | |
| EA200200502A1 (ru) | Способ введения ингибитора фосфодиэстеразы 4 | |
| HRP20050557A2 (en) | Method for improving the pharmacokinetics of a nnrti | |
| BR0114814A (pt) | Composições compreendendo composto de modafinila e seu uso | |
| AR038320A1 (es) | Una dosis de sanorg 34006 para el uso en el tratamiento y profilaxis secundaria de eventos tromboembolicos venosos en pacientes con trombosis venosa profunda | |
| AR052830A1 (es) | Regimen de cladribina para tratar esclerosis multiple | |
| AR131842A1 (es) | Métodos para tratar gliomas | |
| ES2181915T3 (es) | Ctla-8 en combinacionpn con g-csf y il-6, y uso de ctla-8 para tratar infecciones. | |
| AR026705A1 (es) | Forma triturada | |
| AR037291A1 (es) | Uso de una dosis especifica de fondaparinux sodio para el tratamiento de los sindromes coronarios agudos | |
| NO20051261L (no) | Morfin-6-glukuronidsalt | |
| ATE298240T1 (de) | Getrennte dosis therapien mit gefässschädigender aktivität | |
| RU2007148938A (ru) | Способ профилактики ранних послеоперационных тромбоэмболических осложнений | |
| ES2188232T3 (es) | Uso de cetirizina para impedir la aparicion del asma. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |